SPDR Ssga Us L-Cp Low Vol

FDA Approves Johnson & Johnson's RYBREVANT FASPRO for EGFR-Mutated Non-Small Cell Lung Cancer

Walmart Director Walton Steuart L Receives Gift of 239,000 Shares

Walmart Executive Vice President Sells Company Common Stock

David Paddock Plans to Sell General Dynamics Stock

Citigroup Raises Pepsi's Target Price to $170

Walmart CEO Shares Final Reading List

USPS Seeks Bids from Carriers for Low-Density Routes Delivery

Thurston Springer Miller Herd & Titak Inc. Reduced Holdings in Amphenol

CME Group Announces Q4 Earnings

CME Group to Release Q4 and Full Year 2025 Earnings in February 2026

TrustSec Raises Walmart Price Target to $127

Cullen Investment Group Increases Stake in CME Group

RBC Raises Johnson & Johnson's Target Price to $240

PepsiCo Aims to Make Poppi a Billion-Dollar Brand

General Dynamics Information Technology Plans to Provide Cybersecurity and AI Solutions to State Governments

GDIT Secures $285 Million Cybersecurity Contract from Virginia

Increase in VeChain's Blockchain Technology Application at Walmart China

CME Launches TAS Feature for SOL and XRP Futures

FDA Warns Four Retailers for Selling Recalled ByHeart Baby Formula

Deutsche Bank Analyst Maintains Buy Rating on Pepsi

Mega Fortune

Processa Pharmaceuticals

cbdMD

Agape ATP

VYNE Therapeutics

Andersen

Inspirato

Medline Inc.

Creative Global Tech

GCI LIBERTY INC COM USD0.01 SER C SUBS RTS 17/12/2025

The FDA has approved Johnson & Johnson's RYBREVANT FASPRO for EGFR-mutated NSCLC, marking a significant advancement with its subcutaneous administration option. This approval offers a more convenient and faster alternative to intravenous delivery, supported by data showing unmatched overall survival benefits. The news was generated by Public Technologies using AI and is based on Johnson & Johnson's original content from December 17, 2025.

Reuters

Johnson & Johnson

FDA Approves Johnson & Johnson's RYBREVANT FASPRO for EGFR-Mutated NSCLC

David Chojnowski, Vice President of Walmart Inc, filed a Form 4 on December 17, 2025, disclosing the surrender of 252 shares at $116.79 each to pay for option exercise costs and/or tax liabilities. His ending holdings are 136,041 shares directly.

- David Chojnowski, Vice President of Walmart Inc (WMT), filed a Form 4 on December 17, 2025, reporting a change in ownership.  
- On December 16, 2025, he surrendered 252 shares at a price of $116.79, valued at $29,398, to cover the option exercise cost and related tax liability.  
- His remaining direct holdings total 136,041 shares.

Walmart

VP Chojnowski Surrenders 252 Of Walmart Inc [WMT]

Walton Steuart L Director of Walmart Inc [WMT] filed a Form 4 on December 17, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/15/25TransactionGiftShares239,000Price$0.00ValueN/AEnding Holdings: 172,946 (79,292 - Direct, 93,654 - Indirect) For a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

- Walton Steuart L, Director of Walmart Inc, filed a Form 4 with the SEC on December 17, 2025, reporting a gift transaction on December 15, 2025.  
- He gifted 239,000 shares at a price of $0.00, resulting in ending holdings of 172,946 shares (79,292 direct and 93,654 indirect).  
- The Washington Service, founded in 1970, offers financial, economic, and public policy research and data to securities professionals.

Dir Walton Gifts 239,000 Of Walmart Inc [WMT]

The Walton Family Holdings Trust has reported the disposal of common shares of Walmart Inc., a major corporate event. The original filing is available via EDGAR, published by Walmart Inc. on December 17, 2025. This news brief is AI-generated by Public Technologies and is for informational purposes only.

- The Walton Family Holdings Trust has reported a disposal of common shares of Walmart Inc.  
- The original content was published by Walmart Inc. on December 17, 2025, via the EDGAR system.  
- This information is generated for informational purposes and should not be interpreted as financial, investment, or legal advice.

Walton Family Holdings Trust Reports Disposal of Walmart Inc. Common Shares

Daniel J. Bartlett, Executive Vice President of Walmart Inc., reported the sale of common shares of Walmart Inc. The full filing is available via EDGAR, the U.S. SEC's system.

- Daniel J. Bartlett, Executive Vice President of Walmart Inc., reported the disposal of common shares of Walmart Inc.  
- The original filing is available through the U.S. Securities and Exchange Commission's EDGAR system as of December 17, 2025.  
- Public Technologies (PUBT) created this news brief using generative artificial intelligence, emphasizing that it is for informational purposes only.

Walmart Executive Vice President Daniel J. Bartlett Reports Sale of Common Shares

Vulcan Materials Co. (VMC) shares fell 2.26% to $285.41 on Wednesday, underperforming compared to competitors Martin Marietta Materials Inc. and MDU Resources Group Inc. The stock closed 8.45% below its 52-week high, with trading volume surpassing its 50-day average. The decline occurred during a poor trading session for the market, with the S&P 500 and Dow Jones also falling.

Dow Jones

Vulcan Materials

Vulcan Materials Co. Stock Underperforms Wednesday When Compared To Competitors

CTVA

Corteva Inc.'s stock rose 1.45% to $66.43 on Wednesday, despite underperforming compared to competitors like FMC Corp., which rose 4.71%. The stock market had a dismal session, with the S&P 500 and Dow Jones falling. Corteva's stock remains 14.18% below its 52-week high. Trading volume was below the 50-day average.

Corteva

Corteva Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Air Products & Chemicals Inc. (APD) stock rose 1.70% to $246.38 on a day when the overall market declined, with the S&P 500 and Dow Jones falling. The stock remains 27.78% below its 52-week high. Trading volume was higher than average. Competitors showed mixed results: Linde PLC fell, while Dow Inc. and LyondellBasell Industries rose.

Linde

Lyondellbasell Industries NV

Air Products & Chemicals Inc. Stock Outperforms Competitors On Strong Trading Day

Johnson Controls International PLC's stock fell 2.08% to $116.38 on Wednesday, underperforming compared to competitors like Honeywell, which rose 0.82%. The stock is 5.98% below its 52-week high of $123.78. The decline occurred during a poor trading session for the market, with the S&P 500 and Dow Jones also falling.

Johnson Controls

Johnson Controls International PLC Stock Underperforms Wednesday When Compared To Competitors

Krikorian Lazarus, VP of Cencora Inc, filed a Form 4 with the SEC on Dec 17, 2025, disclosing ownership changes. On Dec 15, 2025, he exercised 91 shares at $0.00 and surrendered 91 shares at $350.32, valued at $31,879, to cover option exercise costs and/or tax liabilities. His ending holdings are 21,185 shares directly. The Washington Service provides insider trading analysis and data services.

Cencora

VP Krikorian Acquires 91 Of Cencora Inc [COR]

David Paddock, Vice President of General Dynamics Corp, filed a Form 144 with the SEC to sell 20,360 shares on December 17, 2025, through Fidelity Brokerage Services. The sale must occur within 90 days of filing.

General Dynamics

VP Paddock Files To Sell 20,360 Of General Dynamics Corp [GD]

Four centrist Republicans defied House Speaker Mike Johnson by signing a Democratic-led petition to force a vote on extending Obamacare subsidies for three years. This move challenges Republican leadership, which had pushed a healthcare bill without addressing rising premiums. The petition reached 218 signatures, enabling a floor vote. Johnson maintains control despite the revolt, citing the thin Republican majority. The bill faces challenges in the Republican-led Senate, though some Republican senators support the extension.

南华早报

4 Republicans defy House speaker to force vote on extending Obamacare subsidies

Citi has raised its price target for PepsiCo to $170 from $165, citing the company's strong sales growth, positive 2026 outlook, and efforts to improve PepsiCo Foods North America. The brokerage highlights PepsiCo's international business as undervalued and notes recent product launches boosting volumes. Currently, 9 out of 26 brokerages rate the stock as "buy" or "strong buy."

PepsiCo

BUZZ-Citi raises PT on PepsiCo to $170

Doug McMillon shares his final reading list as Walmart CEO, with topics from AI to basketball to China

businessinsider

Doug McMillon shares his final reading list as Walmart CEO, with topics from AI to basketball to China

The House advanced a GOP health care bill that does not include an extension of ObamaCare subsidies, despite moderate Republicans joining a Democratic petition to extend them. The vote was 213-209. The GOP bill would fund cost-sharing reductions, lowering premiums for some but increasing them for others. Moderates warned that not extending subsidies would raise premiums and hurt the party in 2026. Speaker Mike Johnson opposed an amendment to extend subsidies. A discharge petition by House Minority Leader Hakeem Jeffries to extend subsidies for three years reached the 218-signature threshold to force a vote.